Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON BEER CO INCSAM · Entity 4577 | Director | May 27, 2026 | May 28, 2026 |
| Oscar Health, Inc.OSCR · Entity 3582 | Chief Operating Officer | March 01, 2022 | March 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON BEER CO INC
Report date May 27, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A CommonSEC Table I · non-derivative | Direct | 1,076 |
Reported balance
After 2026-05-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 358 · Balance 1,076 F1: On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date. F2: The shares reported include 358 shares of restricted stock subject to vesting conditions. |
| May 27, 2026 Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $181.63 · Expires 2036-05-26 | Direct | 691 |
Reported balance
After 2026-05-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-27 · Grant · Acquired 691 · Balance 691 F3: On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 27, 2026, the Issuer granted 358 RSUs to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The shares will vest in full on May 12, 2027, provided that the non-employee Director remains a member of the Board of Directors as of that date.
F2: The shares reported include 358 shares of restricted stock subject to vesting conditions.
F3: On May 27, 2026, the Issuer granted 691 option shares to the Reporting Person under the Issuer's Equity Plan for Non-Employee Directors. The option shares are immediately exercisable, subject to the Company's Director Stock Ownership and Retention Guidelines.
Oscar Health, Inc.
Report date March 01, 2022 · Filed March 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 43,070 |
Ending reported balance
After 2022-03-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-03-01 · Exercise / conversion · Acquired 7,016 · Balance 45,610 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2022-03-02 · Sale · Disposed 2,540 · Balance 43,070 F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9105 to $6.915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 98,220 |
Reported balance
After 2022-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-03-01 · Exercise / conversion · Disposed 7,016 · Balance 98,220 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Spouse | 15,896 |
Reported balance
Holding disclosure · report date 2022-03-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 15,896 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9105 to $6.915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Guardant Health, Inc.
Report date June 17, 2026 · Filed June 22, 2026
Section 16 reporting ended · disclosed 2026-06-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,386 |
Reported balance
After 2026-06-17 transaction · row 1
1 source rowRow 1 · 2026-06-17 · Exercise / conversion · Acquired 4,203 · Balance 15,386 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-17 · Exercise / conversion · Disposed 4,203 · Balance 0 F1: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. F2: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
F2: Not applicable for Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2023 Filed Mar 6, 2023 22:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000032 · wf-form4_167814110100704.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2023 Filed Feb 6, 2023 22:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000013 · wf-form4_167572188423378.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,991 Underlying: COMMON STOCK · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| February 04, 2023 Filed Feb 6, 2023 22:18 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000013 · wf-form4_167572188423378.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 23:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 67 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000002 · wf-form4_167296166604856.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,057 Underlying: COMMON STOCK · 67 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 23:34 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000002 · wf-form4_167296166604856.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2022 Filed Dec 6, 2022 22:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000116 · wf-form4_167036542211444.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,124 Underlying: COMMON STOCK · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 04, 2022 Filed Dec 6, 2022 22:24 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000116 · wf-form4_167036542211444.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 67 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000094 · wf-form4_166794504586981.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,190 Underlying: COMMON STOCK · 67 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 22:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 67 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000094 · wf-form4_166794504586981.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 20:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000083 · wf-form4_166508666783282.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,257 Underlying: COMMON STOCK · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 20:04 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000083 · wf-form4_166508666783282.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 20:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000073 · wf-form4_166258299777502.xml · derivative · entry 4 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,323 Underlying: COMMON STOCK · 66 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| September 04, 2022 Filed Sep 7, 2022 20:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 66 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000073 · wf-form4_166258299777502.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2022 Filed Sep 7, 2022 20:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 796 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000073 · wf-form4_166258299777502.xml · derivative · entry 3 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,389 Underlying: COMMON STOCK · 796 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| August 04, 2022 Filed Sep 7, 2022 20:36 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 796 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000073 · wf-form4_166258299777502.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:46 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 5,531 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000038 · wf-form4_165550238233208.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,531 Underlying: COMMON STOCK · 5,531 shares Expires not disclosed F2 · derivative.exercise_date: The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2023. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:46 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 8,789 | $0.00 Strike: $38.42 | $0.00 |
DisclosureSEC source: 0001576280-22-000038 · wf-form4_165550238233208.xml · derivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,789 Underlying: COMMON STOCK · 8,789 shares Expires 2032-06-14 F1 · derivative.exercise_date: The Stock Options vest in full on the one-year anniversary of the grant date, June 15th, 2023. Read SEC document |
| May 18, 2022 Filed May 19, 2022 20:03 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantStock Option · Derivative | 635 | $0.00 Strike: $356.62 | $0.00 |
DisclosureSEC source: 0001562180-22-004237 · primarydocument.xml · derivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635 Underlying: Class A Common · 635 shares Expires 2032-05-17 Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 22:42 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 2,540 | $6.91 | $17,555.46 |
DisclosureSEC source: 0001562180-22-002313 · primarydocument.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,070 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9105 to $6.915, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 7,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002313 · primarydocument.xml · derivative · entry 4 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,220 Underlying: Class A Common Stock · 7,016 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:42 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 7,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-002313 · primarydocument.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 22:11 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 3,090 | $8.75 | $27,037.50 |
DisclosureSEC source: 0001562180-21-007449 · primarydocument.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,594 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 22:11 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 7,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-007449 · primarydocument.xml · derivative · entry 4 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,236 Underlying: Class A Common Stock · 7,015 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. F3 · derivative.expiration_date: The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 22:11 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 7,015 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-007449 · primarydocument.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 23:08 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 58,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-034960 · doc4.xml · derivative · entry 6 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 58,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F6 · derivative.exercise_date: The restricted stock units were granted in January 2021, are fully vested and settled on September 1, 2021. F6 · derivative.expiration_date: The restricted stock units were granted in January 2021, are fully vested and settled on September 1, 2021. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 23:08 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 24,014 | $17.17 | $412,423.64 |
DisclosureSEC source: 0000899243-21-034960 · doc4.xml · nonDerivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,669 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the settlement of previously granted equity awards. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.02 to $17.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 23:08 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 58,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-034960 · doc4.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 23:08 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantStock Option · Derivative | 263,210 | $0.00 Strike: $15.59 | $0.00 |
DisclosureSEC source: 0000899243-21-034960 · doc4.xml · derivative · entry 5 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,210 Underlying: Class A Common Stock · 263,210 shares Expires 2031-08-31 F5 · derivative.exercise_date: The options will vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 23:08 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantRestricted Stock Units · Derivative | 112,251 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-034960 · doc4.xml · derivative · entry 4 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,251 Underlying: Class A Common Stock · 112,251 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units will vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. F4 · derivative.expiration_date: The restricted stock units will vest over a four-year period in 16 equal quarterly installments beginning on December 1, 2021. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 21:00 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionRestricted Stock Units · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-005495 · primarydocument.xml · derivative · entry 3 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 17 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: On March 5, 2021, the reporting person received a grant of 17 RSUs, all of which vested on August 18, 2021. F2 · derivative.expiration_date: On March 5, 2021, the reporting person received a grant of 17 RSUs, all of which vested on August 18, 2021. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 21:00 UTC | Oscar Health, Inc. OSCR · Entity 3582 | Exercise / conversionClass A Common Stock | 17 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-21-005495 · primarydocument.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 21:11 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 5,350 | $0.00 Strike: $113.85 | $0.00 |
DisclosureSEC source: 0001576280-21-000084 · wf-form4_162828425490825.xml · derivative · entry 2 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,350 Underlying: COMMON STOCK · 5,350 shares Expires 2031-08-03 F3 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. Read SEC document |
| August 04, 2021 Filed Aug 6, 2021 21:11 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 3,185 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-21-000084 · wf-form4_162828425490825.xml · derivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,185 Underlying: COMMON STOCK · 3,185 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| May 19, 2021 Filed May 20, 2021 20:02 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantStock Option (Right to Buy) · Derivative | 237 | $0.00 Strike: $1,061.71 | $0.00 |
DisclosureSEC source: 0001562180-21-003639 · primarydocument.xml · derivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237 Underlying: Class A Common · 237 shares Expires 2031-05-18 Read SEC document |
| March 05, 2021 Filed Mar 5, 2021 23:02 UTC | Oscar Health, Inc. OSCR · Entity 3582 | GrantRestricted Stock Units · Derivative | 17 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-010169 · doc4.xml · derivative · entry 3 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Underlying: Class A Common Stock · 17 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) 180 days after the IPO date, or (ii) the second day following the expiration of the underwriter-mandated lock-up period associated with the Issuer's initial public offering. F2 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) 180 days after the IPO date, or (ii) the second day following the expiration of the underwriter-mandated lock-up period associated with the Issuer's initial public offering. Read SEC document |
| March 05, 2021 Filed Mar 5, 2021 23:02 UTC | Oscar Health, Inc. OSCR · Entity 3582 | SaleClass A Common Stock | 95,394 | $39.00 | $3,720,366.00 |
DisclosureSEC source: 0000899243-21-010169 · doc4.xml · nonDerivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 14, 2020 Filed May 14, 2020 20:02 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantStock Option (Right to Buy) · Derivative | 580 | $0.00 Strike: $484.46 | $0.00 |
DisclosureSEC source: 0001562180-20-003617 · primarydocument.xml · derivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580 Underlying: Class A Common · 580 shares Expires 2020-05-13 Read SEC document |
| May 16, 2019 Filed May 16, 2019 20:06 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantStock Option (Right to Buy) · Derivative | 787 | $0.00 Strike: $343.86 | $0.00 |
DisclosureSEC source: 0001562180-19-002866 · primarydocument.xml · derivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 787 Underlying: Class A Common · 787 shares Expires 2029-05-15 Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:25 UTC | BOSTON BEER CO INC SAM · Entity 4577 | GrantClass A Common Stock Option · Derivative | 844 | $0.00 Strike: $315.94 | $0.00 |
DisclosureSEC source: 0001562180-19-001943 · primarydocument.xml · derivative · entry 1 Joyce Meghan V. · CIK 0001770749 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 844 Underlying: Class A Common · 844 shares Expires 2029-03-13 F1 · derivative.underlying_shares: The Reporting Person was granted stock options for 844 shares of the Company's Class A Common Stock, all of which are immediately exercisable, upon her election to the Board of Directors on March 14, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.